Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences

Genetic variants in the OPRM1 and CYP2B6 genes, respectively coding for an opioid receptor and methadone metabolizers, have been linked to negative treatment outcomes in patients undergoing methadone maintenance treatment, with little consensus on their effect. This study aims to test the associatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-12, Vol.16 (12), p.e0261201
Hauptverfasser: Chawar, Caroul, Hillmer, Alannah, Lamri, Amel, Kapczinski, Flavio, Thabane, Lehana, Pare, Guillaume, Samaan, Zainab
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page e0261201
container_title PloS one
container_volume 16
creator Chawar, Caroul
Hillmer, Alannah
Lamri, Amel
Kapczinski, Flavio
Thabane, Lehana
Pare, Guillaume
Samaan, Zainab
description Genetic variants in the OPRM1 and CYP2B6 genes, respectively coding for an opioid receptor and methadone metabolizers, have been linked to negative treatment outcomes in patients undergoing methadone maintenance treatment, with little consensus on their effect. This study aims to test the associations between pre-selected SNPs of OPRM1 and CYP2B6 and outcomes of continued opioid use, relapse, and methadone dose. It also aims to observe differences in associations within the sexes. 1,172 participants treated with methadone (nMale = 666, nFemale = 506) were included in this study. SNPs rs73568641 and rs7451325 from OPRM1 and all the tested CYP2B6 SNPs were detected to be in high linkage disequilibrium. Though no associations were found to be significant, noteworthy differences were observed in associations of OPRM1 rs73568641 and CYP2B6 rs3745274 with treatment outcomes between males and females. Further research is needed to determine if sex-specific differences are present.
doi_str_mv 10.1371/journal.pone.0261201
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2610390661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A686922680</galeid><doaj_id>oai_doaj_org_article_ffb53600968144d8bb507884ce7519f4</doaj_id><sourcerecordid>A686922680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-7a726b0934df2fc9b8fb6c5b64819eeeeb42cbe7d250a665a2959838f93809543</originalsourceid><addsrcrecordid>eNqNk-2K1DAYhYso7rp6B6IBQfDHjPlo02R_COuw6sDKLOsH-CukaTKTpU3GJF3GG_C6zex0lxlQsKW0vHnOyctp3qJ4juAUkRq9vfZDcLKbrr3TU4gpwhA9KI4RJ3hCMSQP976PiicxXkNYEUbp4-KIlBzBuuLHxe95v-6sksl6F4E3YHF59RkB6Vow-3GJ31NwI4OVLuVFB1LQMvXaJeCHpHyvI7AO9DqtZJvbmPTSupQf3YJ1ttRbWQYWuRisPwXnm3Xng3VLEPUGtNYYHbRTOj4tHhnZRf1sfJ8U3z6cf519mlwsPs5nZxcTRTlOk1rWmDaQk7I12CjeMNNQVTW0ZIjrfDUlVo2uW1xBSWklMa84I8xwwiCvSnJSvNz55j6iGCOMIqcHCYeUokzMd0Tr5bVYB9vL8Et4acVtwYelkCFZ1WlhTFMRCiGnDJVly5qmgjVjpdJ1hbjZ7vZu3G1oet2qnEeQ3YHp4YqzK7H0N4LRmlBEs8Gr0SD4n4OO6R8tj9RS5q6sMz6bqd5GJc4oy8FhymCmpn-h8t3q3qr894zN9QPBmwNBZpLepKUcYhTzL1f_zy6-H7Kv99iVll1aRd8Nt0fwECx3oAo-xqDNfXIIiu0M3KUhtjMgxhnIshf7qd-L7g49-QNcXwIq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610390661</pqid></control><display><type>article</type><title>Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Chawar, Caroul ; Hillmer, Alannah ; Lamri, Amel ; Kapczinski, Flavio ; Thabane, Lehana ; Pare, Guillaume ; Samaan, Zainab</creator><contributor>Zhang, Huiping</contributor><creatorcontrib>Chawar, Caroul ; Hillmer, Alannah ; Lamri, Amel ; Kapczinski, Flavio ; Thabane, Lehana ; Pare, Guillaume ; Samaan, Zainab ; Zhang, Huiping</creatorcontrib><description>Genetic variants in the OPRM1 and CYP2B6 genes, respectively coding for an opioid receptor and methadone metabolizers, have been linked to negative treatment outcomes in patients undergoing methadone maintenance treatment, with little consensus on their effect. This study aims to test the associations between pre-selected SNPs of OPRM1 and CYP2B6 and outcomes of continued opioid use, relapse, and methadone dose. It also aims to observe differences in associations within the sexes. 1,172 participants treated with methadone (nMale = 666, nFemale = 506) were included in this study. SNPs rs73568641 and rs7451325 from OPRM1 and all the tested CYP2B6 SNPs were detected to be in high linkage disequilibrium. Though no associations were found to be significant, noteworthy differences were observed in associations of OPRM1 rs73568641 and CYP2B6 rs3745274 with treatment outcomes between males and females. Further research is needed to determine if sex-specific differences are present.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0261201</identifier><identifier>PMID: 34910759</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Alleles ; Analgesics, Opioid - therapeutic use ; Biology and Life Sciences ; Clinical outcomes ; Complications and side effects ; Cytochrome P-450 CYP2B6 - genetics ; Cytochrome P-450 CYP2B6 - metabolism ; Drug dosages ; Female ; Gender aspects ; Gender differences ; Gene Frequency - genetics ; Genetic diversity ; Genetic variance ; Genomes ; Genotype ; Humans ; Linkage disequilibrium ; Linkage Disequilibrium - genetics ; Male ; Medical research ; Medicine and Health Sciences ; Mental disorders ; Metabolism ; Methadone ; Methadone - therapeutic use ; Methadone hydrochloride ; Narcotics ; Neurosciences ; Ontario - epidemiology ; Opiate Substitution Treatment - methods ; Opioid receptors ; Opioid-Related Disorders - drug therapy ; Patient outcomes ; Patients ; People and Places ; Polymorphism, Single Nucleotide - genetics ; Psychiatry ; Receptors, Opioid, mu - genetics ; Receptors, Opioid, mu - metabolism ; Recurrence ; Research methodology ; Sex Characteristics ; Sex differences ; Sex Factors ; Sexes ; Single-nucleotide polymorphism ; Substance-Related Disorders - genetics ; Substance-Related Disorders - metabolism ; Treatment Outcome</subject><ispartof>PloS one, 2021-12, Vol.16 (12), p.e0261201</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Chawar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Chawar et al 2021 Chawar et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-7a726b0934df2fc9b8fb6c5b64819eeeeb42cbe7d250a665a2959838f93809543</citedby><cites>FETCH-LOGICAL-c692t-7a726b0934df2fc9b8fb6c5b64819eeeeb42cbe7d250a665a2959838f93809543</cites><orcidid>0000-0001-7182-0661 ; 0000-0001-8935-5454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673616/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673616/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34910759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Zhang, Huiping</contributor><creatorcontrib>Chawar, Caroul</creatorcontrib><creatorcontrib>Hillmer, Alannah</creatorcontrib><creatorcontrib>Lamri, Amel</creatorcontrib><creatorcontrib>Kapczinski, Flavio</creatorcontrib><creatorcontrib>Thabane, Lehana</creatorcontrib><creatorcontrib>Pare, Guillaume</creatorcontrib><creatorcontrib>Samaan, Zainab</creatorcontrib><title>Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Genetic variants in the OPRM1 and CYP2B6 genes, respectively coding for an opioid receptor and methadone metabolizers, have been linked to negative treatment outcomes in patients undergoing methadone maintenance treatment, with little consensus on their effect. This study aims to test the associations between pre-selected SNPs of OPRM1 and CYP2B6 and outcomes of continued opioid use, relapse, and methadone dose. It also aims to observe differences in associations within the sexes. 1,172 participants treated with methadone (nMale = 666, nFemale = 506) were included in this study. SNPs rs73568641 and rs7451325 from OPRM1 and all the tested CYP2B6 SNPs were detected to be in high linkage disequilibrium. Though no associations were found to be significant, noteworthy differences were observed in associations of OPRM1 rs73568641 and CYP2B6 rs3745274 with treatment outcomes between males and females. Further research is needed to determine if sex-specific differences are present.</description><subject>Adult</subject><subject>Alleles</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Biology and Life Sciences</subject><subject>Clinical outcomes</subject><subject>Complications and side effects</subject><subject>Cytochrome P-450 CYP2B6 - genetics</subject><subject>Cytochrome P-450 CYP2B6 - metabolism</subject><subject>Drug dosages</subject><subject>Female</subject><subject>Gender aspects</subject><subject>Gender differences</subject><subject>Gene Frequency - genetics</subject><subject>Genetic diversity</subject><subject>Genetic variance</subject><subject>Genomes</subject><subject>Genotype</subject><subject>Humans</subject><subject>Linkage disequilibrium</subject><subject>Linkage Disequilibrium - genetics</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Mental disorders</subject><subject>Metabolism</subject><subject>Methadone</subject><subject>Methadone - therapeutic use</subject><subject>Methadone hydrochloride</subject><subject>Narcotics</subject><subject>Neurosciences</subject><subject>Ontario - epidemiology</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Opioid receptors</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>People and Places</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Psychiatry</subject><subject>Receptors, Opioid, mu - genetics</subject><subject>Receptors, Opioid, mu - metabolism</subject><subject>Recurrence</subject><subject>Research methodology</subject><subject>Sex Characteristics</subject><subject>Sex differences</subject><subject>Sex Factors</subject><subject>Sexes</subject><subject>Single-nucleotide polymorphism</subject><subject>Substance-Related Disorders - genetics</subject><subject>Substance-Related Disorders - metabolism</subject><subject>Treatment Outcome</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk-2K1DAYhYso7rp6B6IBQfDHjPlo02R_COuw6sDKLOsH-CukaTKTpU3GJF3GG_C6zex0lxlQsKW0vHnOyctp3qJ4juAUkRq9vfZDcLKbrr3TU4gpwhA9KI4RJ3hCMSQP976PiicxXkNYEUbp4-KIlBzBuuLHxe95v-6sksl6F4E3YHF59RkB6Vow-3GJ31NwI4OVLuVFB1LQMvXaJeCHpHyvI7AO9DqtZJvbmPTSupQf3YJ1ttRbWQYWuRisPwXnm3Xng3VLEPUGtNYYHbRTOj4tHhnZRf1sfJ8U3z6cf519mlwsPs5nZxcTRTlOk1rWmDaQk7I12CjeMNNQVTW0ZIjrfDUlVo2uW1xBSWklMa84I8xwwiCvSnJSvNz55j6iGCOMIqcHCYeUokzMd0Tr5bVYB9vL8Et4acVtwYelkCFZ1WlhTFMRCiGnDJVly5qmgjVjpdJ1hbjZ7vZu3G1oet2qnEeQ3YHp4YqzK7H0N4LRmlBEs8Gr0SD4n4OO6R8tj9RS5q6sMz6bqd5GJc4oy8FhymCmpn-h8t3q3qr894zN9QPBmwNBZpLepKUcYhTzL1f_zy6-H7Kv99iVll1aRd8Nt0fwECx3oAo-xqDNfXIIiu0M3KUhtjMgxhnIshf7qd-L7g49-QNcXwIq</recordid><startdate>20211215</startdate><enddate>20211215</enddate><creator>Chawar, Caroul</creator><creator>Hillmer, Alannah</creator><creator>Lamri, Amel</creator><creator>Kapczinski, Flavio</creator><creator>Thabane, Lehana</creator><creator>Pare, Guillaume</creator><creator>Samaan, Zainab</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7182-0661</orcidid><orcidid>https://orcid.org/0000-0001-8935-5454</orcidid></search><sort><creationdate>20211215</creationdate><title>Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences</title><author>Chawar, Caroul ; Hillmer, Alannah ; Lamri, Amel ; Kapczinski, Flavio ; Thabane, Lehana ; Pare, Guillaume ; Samaan, Zainab</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-7a726b0934df2fc9b8fb6c5b64819eeeeb42cbe7d250a665a2959838f93809543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Alleles</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Biology and Life Sciences</topic><topic>Clinical outcomes</topic><topic>Complications and side effects</topic><topic>Cytochrome P-450 CYP2B6 - genetics</topic><topic>Cytochrome P-450 CYP2B6 - metabolism</topic><topic>Drug dosages</topic><topic>Female</topic><topic>Gender aspects</topic><topic>Gender differences</topic><topic>Gene Frequency - genetics</topic><topic>Genetic diversity</topic><topic>Genetic variance</topic><topic>Genomes</topic><topic>Genotype</topic><topic>Humans</topic><topic>Linkage disequilibrium</topic><topic>Linkage Disequilibrium - genetics</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Mental disorders</topic><topic>Metabolism</topic><topic>Methadone</topic><topic>Methadone - therapeutic use</topic><topic>Methadone hydrochloride</topic><topic>Narcotics</topic><topic>Neurosciences</topic><topic>Ontario - epidemiology</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Opioid receptors</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>People and Places</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Psychiatry</topic><topic>Receptors, Opioid, mu - genetics</topic><topic>Receptors, Opioid, mu - metabolism</topic><topic>Recurrence</topic><topic>Research methodology</topic><topic>Sex Characteristics</topic><topic>Sex differences</topic><topic>Sex Factors</topic><topic>Sexes</topic><topic>Single-nucleotide polymorphism</topic><topic>Substance-Related Disorders - genetics</topic><topic>Substance-Related Disorders - metabolism</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chawar, Caroul</creatorcontrib><creatorcontrib>Hillmer, Alannah</creatorcontrib><creatorcontrib>Lamri, Amel</creatorcontrib><creatorcontrib>Kapczinski, Flavio</creatorcontrib><creatorcontrib>Thabane, Lehana</creatorcontrib><creatorcontrib>Pare, Guillaume</creatorcontrib><creatorcontrib>Samaan, Zainab</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chawar, Caroul</au><au>Hillmer, Alannah</au><au>Lamri, Amel</au><au>Kapczinski, Flavio</au><au>Thabane, Lehana</au><au>Pare, Guillaume</au><au>Samaan, Zainab</au><au>Zhang, Huiping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-12-15</date><risdate>2021</risdate><volume>16</volume><issue>12</issue><spage>e0261201</spage><pages>e0261201-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Genetic variants in the OPRM1 and CYP2B6 genes, respectively coding for an opioid receptor and methadone metabolizers, have been linked to negative treatment outcomes in patients undergoing methadone maintenance treatment, with little consensus on their effect. This study aims to test the associations between pre-selected SNPs of OPRM1 and CYP2B6 and outcomes of continued opioid use, relapse, and methadone dose. It also aims to observe differences in associations within the sexes. 1,172 participants treated with methadone (nMale = 666, nFemale = 506) were included in this study. SNPs rs73568641 and rs7451325 from OPRM1 and all the tested CYP2B6 SNPs were detected to be in high linkage disequilibrium. Though no associations were found to be significant, noteworthy differences were observed in associations of OPRM1 rs73568641 and CYP2B6 rs3745274 with treatment outcomes between males and females. Further research is needed to determine if sex-specific differences are present.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34910759</pmid><doi>10.1371/journal.pone.0261201</doi><tpages>e0261201</tpages><orcidid>https://orcid.org/0000-0001-7182-0661</orcidid><orcidid>https://orcid.org/0000-0001-8935-5454</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-12, Vol.16 (12), p.e0261201
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2610390661
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Adult
Alleles
Analgesics, Opioid - therapeutic use
Biology and Life Sciences
Clinical outcomes
Complications and side effects
Cytochrome P-450 CYP2B6 - genetics
Cytochrome P-450 CYP2B6 - metabolism
Drug dosages
Female
Gender aspects
Gender differences
Gene Frequency - genetics
Genetic diversity
Genetic variance
Genomes
Genotype
Humans
Linkage disequilibrium
Linkage Disequilibrium - genetics
Male
Medical research
Medicine and Health Sciences
Mental disorders
Metabolism
Methadone
Methadone - therapeutic use
Methadone hydrochloride
Narcotics
Neurosciences
Ontario - epidemiology
Opiate Substitution Treatment - methods
Opioid receptors
Opioid-Related Disorders - drug therapy
Patient outcomes
Patients
People and Places
Polymorphism, Single Nucleotide - genetics
Psychiatry
Receptors, Opioid, mu - genetics
Receptors, Opioid, mu - metabolism
Recurrence
Research methodology
Sex Characteristics
Sex differences
Sex Factors
Sexes
Single-nucleotide polymorphism
Substance-Related Disorders - genetics
Substance-Related Disorders - metabolism
Treatment Outcome
title Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A48%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implications%20of%20OPRM1%20and%20CYP2B6%20variants%20on%20treatment%20outcomes%20in%20methadone-maintained%20patients%20in%20Ontario:%20Exploring%20sex%20differences&rft.jtitle=PloS%20one&rft.au=Chawar,%20Caroul&rft.date=2021-12-15&rft.volume=16&rft.issue=12&rft.spage=e0261201&rft.pages=e0261201-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0261201&rft_dat=%3Cgale_plos_%3EA686922680%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610390661&rft_id=info:pmid/34910759&rft_galeid=A686922680&rft_doaj_id=oai_doaj_org_article_ffb53600968144d8bb507884ce7519f4&rfr_iscdi=true